Table 1.

Participant Characteristics

Consumers
(n = 379)
HCPs
(n = 368)
Female202 (53.3%)119 (32.3%)
Age - Mean (SD)53.4 (17.1)50.9 (12.6)
Race/ethnicity
 White (non-Hispanic)261 (68.9%)210 (57.1%)
 Black (non-Hispanic)35 (9.2%)9 (2.4%)
 Asian (non-Hispanic)15 (4.0%)86 (23.4%)
 American Indian (non-Hispanic)2 (0.5%)2 (0.5%)
 Native Hawaiian (non-Hispanic)2 (0.5%)1 (0.3%)
 Multiracial (non-Hispanic)8 (2.1%)5 (1.4%)
 Other (non-Hispanic)6 (1.6%)6 (1.6%)
 Hispanic38 (10.0%)21 (5.7%)
 Refused/Missing12 (3.2%)28 (7.6%)
Education
 High school or less54 (14.3%)
 Some college110 (29.0%)
 Associates degree87 (23.0%)
 Bachelor’s degree or higher128 (33.8%)
Familiarity with Biosimilars
 Aware55 (14.5%)267 (72.6%)
Training and practice
 Medical Doctor/Physician327 (88.9%)
 Physician assistant16 (4.3%)
 Nurse practitioner25 (6.8%)
 Average prescriptions weekly- Mean (SD)129.9 (142.5)
 Average years in medical practice -Mean (SD)18.9 (11.1)
Consumer experience with condition
 Ever diagnosed with rheumatoid arthritis36 (9.5%)
 Ever taken prescription for rheumatoid arthritis29 (7.6%)
  • Abbreviations: HCPs, Health care providers; SD, Standard deviation.